Mechanisms for Axonal Guidance Using Living Tissue Engineered Scaffolds
Mechanisms for Axonal Guidance Using Living Tissue Engineered Scaffolds
批准号:
8983595
负责人:
Kritika Katiyar
金额:
$2.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-01 至 2018-08-31
关键词:
AddressAffectArchitectureAutomobile DrivingAxonBedsBiocompatible MaterialsBioreactorsBrainCell Adhesion MoleculesCellsCellular StructuresConfocal MicroscopyCouplingCuesCustomDefectDevelopmentEngineeringEnvironmentFamily suidaeFeedbackFellowshipGoldGrowthImmunohistochemistryImplantInjuryLengthLifeMalignant NeoplasmsMeasuresMediatingMediator of activation proteinMicroscopyMolecularMorbidity - disease rateNatural regenerationNerveNerve DegenerationNerve RegenerationNervous System TraumaNeuraxisNeurodegenerative DisordersNeuronsNeuropathyOperative Surgical ProceduresPathologyPathway interactionsPeripheralPeripheral Nervous SystemPeripheral Nervous System DiseasesPeripheral nerve injuryPopulationProceduresProcessRecoveryRecovery of FunctionRegenerative MedicineResearch PersonnelResolutionRodentRodent ModelRoleSignal TransductionSiteSpatial DistributionSpinal CordStretchingStrokeSurfaceSystemTechniquesTechnologyTestingTimeTissue EngineeringTissuesTransplanted tissueTraumaaxon growthaxon guidanceaxon regenerationaxonal degenerationaxonal guidanceaxonal pathfindingbasecell motilityfunctional restorationimmunocytochemistryimprovedin vitro testingin vivoinnovationmigrationnerve autograftnervous system disorderneural circuitneurodevelopmentneurological recoveryneurotrophic factornovelpreferencepreventpublic health relevanceregenerativerelating to nervous systemrepairedscaffold
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Neurotrauma and neurodegenerative diseases affect millions of people annually. A common pathology is the loss of long-distance connections, specifically axons connecting regions of the central nervous system or relaying peripheral signals. This axonal degeneration may result in permanent deficits. Due to the lack of spontaneous regenerative capability of long-distance axonal connections in the central and peripheral nervous system, researchers are developing tissue engineered constructs to reverse the effects of trauma or neurodegenerative disease. Successful application involves the integration of engineered living tissue to directly restore lost function or create a more suitable
environment for regeneration. To facilitate axon regeneration, we utilize novel tissue engineered nerve grafts (TENGs) comprised of long, aligned axonal tracts generated by "stretch-growth", a natural mechanism that is replicated in custom mechano-bioreactors to generate axons of unprecedented lengths in a short period of time. The axonal tracts serve as a living scaffold for neuroregeneration. In previous rodent and swine studies, the living axonal tracts in TENGs have been seen to serve as "guidance paths" to direct regenerating axons, with regenerating host axons growing directly along transplanted TENG axons, demonstrating direct axon mediated axon regeneration (AMAR). However, the molecular mediators responsible for this phenomenon remain unknown, yet are crucial to further enhance this technology. Therefore, during my fellowship tenure, I intend to elucidate the molecular mediators primarily responsible for AMAR by developing an in vitro test bed and utilizing an innovative in vivo axon regeneration paradigm to systematically elucidate the cellular factors primarily driving AMAR. Specifically, I hypothesiz that juxtacrine signaling - a combination of axon-surface cues and concomitant intimate presentation of soluble factors - drives AMAR. This hypothesis will be tested through immunohistochemistry, confocal microscopy, super resolution microscopy, as well as electrophysiological analyses for functional recovery in rodents. Determining the precise juxtacrine signaling involved in AMAR is broadly applicable to improving peripheral as well as central nervous system repair and regeneration, thus ultimately improving neurological recovery following a range of traumatic injuries or neurodegenerative diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Tissue Engineered Neuromuscular Interfaces from GalSafe Neurons.
-
批准号:10385405
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2022
-
负责人:Kritika Katiyar
-
依托单位:
Generation of Tissue Engineered Nerve Grafts from GalSafe Porcine Neurons
-
批准号:10473788
-
项目类别:
-
资助金额:$90.1万
-
财政年份:2018
-
负责人:Kritika Katiyar
-
依托单位:
Generation of Tissue Engineered Nerve Grafts from GalSafe Porcine Neurons
-
批准号:10268167
-
项目类别:
-
资助金额:$93.41万
-
财政年份:2018
-
负责人:Kritika Katiyar
-
依托单位:
Generation of Tissue Engineered Nerve Grafts from GalSafe Porcine Neurons
-
批准号:10011078
-
项目类别:
-
资助金额:$108.34万
-
财政年份:2018
-
负责人:Kritika Katiyar
-
依托单位:
Mechanisms for Axonal Guidance Using Living Tissue Engineered Scaffolds
-
批准号:9335678
-
项目类别:
-
资助金额:$3.07万
-
财政年份:2015
-
负责人:Kritika Katiyar
-
依托单位:
海外基金